The role of MRI/TRUS fusion biopsy in the diagnosis of clinically significant prostate cancer

BACKGROUND: The aim of this work is to evaluate the detection rate of magnetic resonance imaging/transrectal ultrasound (MRI/TRUS) fusion-guided biopsy for clinically significant prostate cancers (Cs PCas), with particular interest in biopsy-naive patients and patients in active surveillance. MRI-ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Benelli, Andrea, Vaccaro, Chiara, Guzzo, Sonia, Nedbal, Carlotta, Varca, Virginia, Gregori, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238303/
https://www.ncbi.nlm.nih.gov/pubmed/32489424
http://dx.doi.org/10.1177/1756287220916613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238303/
https://www.ncbi.nlm.nih.gov/pubmed/32489424
http://dx.doi.org/10.1177/1756287220916613

Ejemplares similares